R

Rekah Pharmaceutical Industry Ltd
TASE:REKA

Watchlist Manager
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Watchlist
Price: 1 481 ILS -1.2% Market Closed
Market Cap: 175.3m ILS
Have any thoughts about
Rekah Pharmaceutical Industry Ltd?
Write Note

DCF Value

This DCF valuation model was created by Alpha Spread and was last updated on Nov 13, 2024.

Estimated DCF Value of one REKA stock is 1 425.7 ILS. Compared to the current market price of 1 481 ILS, the stock is Overvalued by 4%.

REKA DCF Value
Base Case
1 425.7 ILS
Overvaluation 4%
DCF Value
Price
R
Worst Case
Base Case
Best Case
1 425.7
DCF Value
Worst Case
Base Case
Best Case
Hide
DCF Value: 1 425.7 ILS

Present Value Calculation

This block is the starting point of the DCF valuation process. It calculates the present value of a company's forecasted cash flows based on selected operating model. Adjust key parameters like discount rate and terminal growth, and alter inputs such as revenue growth and margins to see their impact on valuation.

DCF Model
Base Case Scenario

The present value of cash flows over the next 5 years amounts to 82.9m ILS. The present value of the terminal value is 203.5m ILS. The total present value equals 286.3m ILS.
Forecast Period
Years
Discount Rate
%
Show All DCF Settings
Terminal Growth
%
Hide DCF Settings
Save

DCF Value Calculation

This stage translates the present value into DCF value per share. For firm valuation models, it adjusts present value for debt and assets to derive equity value (skipped if using equity valuation model). Finally, this equity value is divided by the number of shares to determine the DCF value per share.

Present Value to DCF Value
Capital Structure

Present Value 286.3m ILS
+ Cash & Equivalents 5.4m ILS
+ Investments 1.2m ILS
Firm Value 293m ILS
- Debt 124.1m ILS
- Minority Interest 48k ILS
Equity Value 168.8m ILS
/ Shares Outstanding 118.4k
REKA DCF Value 1 425.7 ILS
Overvalued by 4%

Valuation Analysis

Sensitivity Analysis
DCF Value Sensitivity Analysis

Sensitivity Analysis assesses how changes in key factors like revenue growth, margin, and discount rate affect a stock's DCF value. By visualizing various scenarios, from significant downturns to optimistic growth, this tool helps you understand potential valuation shifts, aiding in risk assessment and strategic decision-making.

DCF Financials
Financials used in DCF Calculation

Revenue
346.7m 410.6m
Operating Income
19.7m 30.4m
FCFF
17.8m 24.9m

See Also

Discover More

What is the DCF value of one REKA stock?

Estimated DCF Value of one REKA stock is 1 425.7 ILS. Compared to the current market price of 1 481 ILS, the stock is Overvalued by 4%.

The true DCF Value lies somewhere between the worst-case and best-case scenario values. This is because the future is not predetermined, and the stock's DCF Value is based almost entirely on the future of the company. Knowing the full range of possible stock DCF values gives a complete picture of the investment risks and opportunities.

How was the DCF Value calculated?

1. Present Value Calculation. Utilizing the DCF operating model, Rekah Pharmaceutical Industry Ltd's future cash flows are projected and then discounted using a chosen discount rate to determine its Present Value, which is calculated at 286.3m ILS.

2. DCF Value Calculation. The company's capital structure is employed to derive the total Equity Value from the previously calculated Present Value of the cash flow. This Equity Value, when divided by the total number of outstanding shares, yields the DCF Value of 1 425.7 ILS per share.

Back to Top
//